Cargando…
Reactive Oxygen Species Modulator 1 is Associated with Poor Survival in Patients with Non-Small Cell Lung Cancer After Stereotactic Fractionated Radiosurgery: A Retrospective Pilot Study
PURPOSE: It has been reported that the overexpression of reactive oxygen species modulator 1 (Romo1) is significantly associated with poor survival outcomes in patients with lung cancer who received surgical resection, conventional fractionated radiotherapy, and chemotherapy. In this study, we inves...
Autores principales: | Kong, Moonkyoo, Sung, Ji-Youn, Lee, Seung Hyeun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455601/ https://www.ncbi.nlm.nih.gov/pubmed/32904444 http://dx.doi.org/10.2147/OTT.S266344 |
Ejemplares similares
-
Reactive Oxygen Species Modulator 1 As An Adverse Prognostic Marker In Stage III Non-Small Cell Lung Cancer Treated With Radiotherapy: A Retrospective Pilot Study
por: Kong, Moonkyoo, et al.
Publicado: (2019) -
RADI-18. STEREOTACTIC RADIOSURGERY OR FRACTIONATED STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES FROM SMALL CELL LUNG CANCER
por: Thomas, Evan, et al.
Publicado: (2019) -
SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases
por: Crouzen, J. A., et al.
Publicado: (2023) -
Single fraction stereotactic radiosurgery for multiple brain metastases
por: Limon, Dror, et al.
Publicado: (2017) -
Effects of two different radiotherapies for craniopharyngiomas using stereotactic radiosurgery/ stereotactic radiotherapy or fractionated stereotactic radiotherapy
por: Kamogawa, Misaki, et al.
Publicado: (2022)